Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093625 · ClinicalTrials.gov registry record · NA
Assessment of Daily Disposable Silicone Hydrogel Lens Wear
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 157
- Enrollment target
NCT01093625 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 157 participants.
The verdict
NCT01093625, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of an investigational silicone hydrogel soft contact lens on new contact lens wearers (neophytes) compared to a control of spectacle wearers.
Interventions
- DEVICE Spectacles
- DEVICE Narafilcon B Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01093625
The ClinicalTrials.gov registry entry for NCT01093625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Spectacles is the first listed.
NCT01093625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01093625 about?
NCT01093625 is a clinical study titled "Assessment of Daily Disposable Silicone Hydrogel Lens Wear". The purpose of this study is to evaluate the effect of an investigational silicone hydrogel soft contact lens on new contact lens wearers (neophytes) compared to a control of spectacle wearers.
What is the current status of trial NCT01093625?
This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2010-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01093625?
The interventions under investigation include: Spectacles (DEVICE), Narafilcon B Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT01093625?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.